Craft
  • Home
  •  / Confo Therapeutics
Confo Therapeutics

Confo Therapeutics

Total Funding

$46 M

Confo Therapeutics Summary

Company summary

Overview
Confo Therapeutics is a drug discovery company based on disruptive technology to enable the discovery of G-protein-coupled receptors (GPCR) agonists. Its technology utilizes single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for drug discovery.
Type
Private
Founded
2015
HQ
Elsene, BE | view all locations
Website
http://confotherapeutics.com
Cybersecurity rating
Sectors

Key people

  • Cedric Ververken

    Cedric Ververken, Chief Executive Officer and Director

  • John Berriman

    John Berriman, Chairman

    • Christel Menet

      Christel Menet, Chief Scientific Officer

    • Rob Scott

      Rob Scott, Independent Director

      LocationsView all

      2 locations detected

      • Elsene, Brussels Hoofdstedelijk Gewest HQ

        Belgium

        Pleinlaan 2/building e, 7th floor

      • Gent, Vlaanderen

        Belgium

        Technologiepark-Zwijnaarde 94

      Footer menu